STERIS plc Operating Income
STERIS plc (STE) reported Operating Income of $285.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- STERIS plc operating income (loss) for the quarter ending 2026-06-30 was $285.80M, a 16.18% increase year-over-year.
- STERIS plc operating income (loss) for the quarter ending 2026-03-31 was $316.80M, a 46.60% increase year-over-year.
- STERIS plc operating income (loss) for the quarter ending 2025-12-31 was $273.20M, a 11.37% increase year-over-year.
- STERIS plc operating income (loss) for the quarter ending 2025-09-30 was $265.80M, a 20.98% increase year-over-year.
- STERIS plc operating income (loss) for fiscal 2026 was $1.10B, a 27.14% increase from fiscal 2025.
- STERIS plc operating income (loss) for fiscal 2025 was $866.60M, a 3.65% increase from fiscal 2024.
- STERIS plc operating income (loss) for fiscal 2024 was $836.10M, a 5.69% increase from fiscal 2023.
- STERIS plc operating income (loss) for fiscal 2023 was $791.10M, a 65.57% increase from fiscal 2022.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $285.80M 10-Q · filed 2026-08-07 | $602.60M derived: sum of 2 quarters · filed 2026-08-07 | $875.80M derived: sum of 3 quarters · filed 2026-08-07 | $1.14B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $316.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $590.00M derived: sum of 2 quarters · filed 2026-05-29 | $855.80M derived: sum of 3 quarters · filed 2026-05-29 | $1.10B 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $273.20M 10-Q · filed 2026-02-06 | $539.00M derived: sum of 2 quarters · filed 2026-02-06 | $785.00M 10-Q · filed 2026-02-06 | $1.00B derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $265.80M 10-Q · filed 2025-11-06 | $511.80M 10-Q · filed 2025-11-06 | $727.90M derived: sum of 3 quarters · filed 2026-08-07 | $973.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $246.00M 10-Q · filed 2026-08-07 | $462.10M derived: sum of 2 quarters · filed 2026-08-07 | $707.40M derived: sum of 3 quarters · filed 2026-08-07 | $927.10M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $216.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $461.40M derived: sum of 2 quarters · filed 2026-05-29 | $681.10M derived: sum of 3 quarters · filed 2026-05-29 | $866.60M 10-K · filed 2026-05-29 | $866.64M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $245.30M 10-Q · filed 2026-02-06 | $245.29M 10-Q · filed 2025-02-07 | $465.00M derived: sum of 2 quarters · filed 2026-02-06 | $650.50M 10-Q · filed 2026-02-06 | $650.49M 10-Q · filed 2025-02-07 | $870.82M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-09-30 | $219.70M 10-Q · filed 2025-11-06 | $219.67M 10-Q · filed 2024-11-07 | $405.20M 10-Q · filed 2025-11-06 | $405.20M 10-Q · filed 2024-11-07 | $625.52M derived: sum of 3 quarters · filed 2026-05-29 | $851.99M derived: sum of 4 quarters · filed 2026-05-29 | ||
| 2024-06-30 | $185.50M 10-Q · filed 2025-08-07 | $185.53M 10-Q · filed 2024-08-08 | $405.82M derived: sum of 2 quarters · filed 2026-05-29 | $632.29M derived: sum of 3 quarters · filed 2026-05-29 | $823.84M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $220.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $446.79M derived: sum of 2 quarters · filed 2026-05-29 | $638.34M derived: sum of 3 quarters · filed 2026-05-29 | $836.10M 10-K · filed 2026-05-29 | $836.12M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $226.47M 10-Q · filed 2025-02-07 | $216.16M 10-Q · filed 2024-02-08 | $418.02M derived: sum of 2 quarters · filed 2025-02-07 | $615.78M 10-Q · filed 2025-02-07 | $590.89M 10-Q · filed 2024-02-08 | $1.36B derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-09-30 | $191.55M 10-Q · filed 2024-11-07 | $185.86M 10-Q · filed 2023-11-07 | $389.31M 10-Q · filed 2024-11-07 | $374.74M 10-Q · filed 2023-11-07 | $1.14B derived: sum of 3 quarters · filed 2025-05-29 | $1.33B derived: sum of 4 quarters · filed 2025-05-29 | ||
| 2023-06-30 | $197.76M 10-Q · filed 2024-08-08 | $188.88M 10-Q · filed 2023-08-08 | $946.08M derived: sum of 2 quarters · filed 2025-05-29 | $1.14B derived: sum of 3 quarters · filed 2025-05-29 | $830.47M derived: sum of 4 quarters · filed 2025-05-29 | |||
| 2023-03-31 | $748.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $939.12M derived: sum of 2 quarters · filed 2025-05-29 | $632.71M derived: sum of 3 quarters · filed 2025-05-29 | $791.10M 10-K · filed 2025-05-29 | $268.19M 10-K · filed 2023-05-26 | |||
| 2022-12-31 | $190.80M 10-Q · filed 2024-02-08 | -$115.61M derived: sum of 2 quarters · filed 2024-02-08 | $42.78M 10-Q · filed 2024-02-08 | $186.84M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | -$306.42M 10-Q · filed 2023-11-07 | -$148.02M 10-Q · filed 2023-11-07 | -$3.96M derived: sum of 3 quarters · filed 2024-05-29 | $198.97M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $158.40M 10-Q · filed 2023-08-08 | $302.45M derived: sum of 2 quarters · filed 2024-05-29 | $505.38M derived: sum of 3 quarters · filed 2024-05-29 | $621.89M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $144.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $346.99M derived: sum of 2 quarters · filed 2024-05-29 | $463.49M derived: sum of 3 quarters · filed 2024-05-29 | $477.81M 10-K · filed 2024-05-29 | $425.62M 10-K · filed 2022-05-31 | |||
| 2021-12-31 | $202.93M 10-Q · filed 2023-02-08 | $319.44M derived: sum of 2 quarters · filed 2023-02-08 | $333.76M 10-Q · filed 2023-02-08 | $478.02M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $116.50M 10-Q · filed 2022-11-09 | $130.83M 10-Q · filed 2022-11-09 | $275.08M derived: sum of 3 quarters · filed 2023-05-26 | $422.12M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $14.32M 10-Q · filed 2022-08-08 | $158.58M derived: sum of 2 quarters · filed 2023-05-26 | $305.61M derived: sum of 3 quarters · filed 2023-05-26 | $446.88M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $144.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $291.29M derived: sum of 2 quarters · filed 2023-05-26 | $432.55M derived: sum of 3 quarters · filed 2023-05-26 | $548.37M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $147.03M 10-Q · filed 2022-02-09 | $288.29M derived: sum of 2 quarters · filed 2022-02-09 | $404.11M 10-Q · filed 2022-02-09 | $402.29M 10-Q · filed 2021-02-09 | $561.95M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-09-30 | $141.26M 10-Q · filed 2021-11-08 | $257.08M 10-Q · filed 2021-11-08 | $255.26M 10-Q · filed 2020-11-06 | $414.92M derived: sum of 3 quarters · filed 2022-05-31 | $557.30M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-06-30 | $115.82M 10-Q · filed 2021-08-09 | $114.00M 10-Q · filed 2020-08-07 | $273.65M derived: sum of 2 quarters · filed 2022-05-31 | $416.04M derived: sum of 3 quarters · filed 2022-05-31 | $542.77M derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2020-03-31 | $157.84M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $300.23M derived: sum of 2 quarters · filed 2022-05-31 | $426.96M derived: sum of 3 quarters · filed 2022-05-31 | $537.05M 10-K · filed 2022-05-31 | $536.97M 10-K · filed 2020-05-29 | |||
| 2019-12-31 | $142.39M 10-Q · filed 2021-02-09 | $269.12M derived: sum of 2 quarters · filed 2021-02-09 | $379.21M 10-Q · filed 2021-02-09 | $519.64M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $126.73M 10-Q · filed 2020-11-06 | $236.82M 10-Q · filed 2020-11-06 | $377.26M derived: sum of 3 quarters · filed 2021-05-28 | $446.84M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $110.09M 10-Q · filed 2020-08-07 | $250.53M derived: sum of 2 quarters · filed 2021-05-28 | $320.11M derived: sum of 3 quarters · filed 2021-05-28 | $426.69M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $140.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $210.02M derived: sum of 2 quarters · filed 2021-05-28 | $316.60M derived: sum of 3 quarters · filed 2021-05-28 | $411.02M 10-K · filed 2021-05-28 | $411.46M 10-K · filed 2019-05-30 | |||
| 2018-12-31 | $69.58M 10-Q · filed 2020-02-10 | $176.16M derived: sum of 2 quarters · filed 2020-02-10 | $270.59M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $106.58M 10-Q · filed 2019-11-07 | $201.00M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $94.42M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $399.88M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $226.21M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |